Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

By Carly Helfand May 21, 2014 10:21am

Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

NEW YORK, May 15, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p02116909/Meningococcal-Vaccines-Market-Polysaccharide-Conjugate-and-Combination-Vaccines-along-with-Pipeline-Analysis---Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast-2013---2019.html

The global meningococcal vaccines market is studied on the basis of vaccine types such as polysaccharide, conjugate and combination vaccines. The vaccine types are further segmented into different brands. The report also highlights and analyzes various brands under pipeline segment, namely, Bexsero, MnB rLP2806 and NmVac-4DT. A detailed market analysis and forecast for these segments has been provided in this study, in terms of revenue (USD million) for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each meningococcal vaccine segment and brand for the forecast period 2013 to 2019, while market size estimations have been made considering 2011 and 2012 as the base years.

In terms of geographical distribution, the global meningococcal vaccines market has been classified into four major geographical areas, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The current and future market sizes (in terms of USD million) of the above regional markets have been provided in the report for the period 2011 to 2019 with their growth rate (%) for the period 2013 to 2019. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and flourish in the global meningococcal vaccines market.

The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints and opportunities that influence the current and future status of this industry. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global meningococcal vaccines market.

The report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include Sanofi S.A., Novartis International AG, GlaxoSmithKline plc, Pfizer, Inc., Serum Institute of India, Ltd., JN-International Medical Corporation, Nuron Biotech, Baxter International and Biomed Pvt. Ltd.

The global meningococcal vaccines market is segmented as follow:Meningococcal Vaccines Market, by Type

Polysaccharide Vaccines, by Brand

Menomune

Mencevax

NmVac4

Others

Quadri Meningo

Bi Meningo

Conjugate Vaccines, by Brand

Menactra

Menveo

NeisVac-C

Nimenrix

Meningitec

Menjugate

MenAfriVac

Combination Vaccines, by Brand

MenHibrix

Menitorix

Pipeline Vaccines, by Brand

Bexsero

MnB rLP2806

NmVac4-DT

Meningococcal Vaccines Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.3.1 Secondary Research

1.3.2 Primary Research

1.4 List of Abbreviations

1.5 Assumptions

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Meningococcal Vaccines Market

2.2 Global Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

2.3 Comparative Analysis: Global Meningococcal Vaccines Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 Global Meningococcal Vaccines Market Overview

3.1 Introduction

3.1.1 Meningococcal Disease

3.1.1.1 Clinical Features

3.1.1.2 Epidemiology

3.1.1.3 Diagnosis & Treatment

3.1.2 Types of Meningococcal Vaccines

3.2 Regulatory Scenario

3.3 Market Drivers

3.3.1 Developing economies reshaping global health and development

3.3.2 Education and awareness through various non-profit organizations

3.3.3 Travel vaccines for meningococcal disease

3.4 Market Restraints

3.4.1 Disparate age groups and dosage regimen for routine immunization, and unpredictable and dynamic epidemiology of meningococcal disease

3.4.2 Maintenance of cold chains to deliver vaccines leading to high cost of vaccination

3.5 Market Opportunities

3.5.1 Development of vaccines through collaborations and public private partnerships making vaccines more affordable

3.5.2 Novel approaches to improve the stability of meningococcal vaccines

3.5.3 Developing halal vaccines

3.6 Porter's Five Force Analysis for the Global Meningococcal Vaccines Market

3.6.1 Bargaining Power of Suppliers

3.6.2 Bargaining Power of Buyers

3.6.3 Threat of Substitutes

3.6.4 Threat of New Entrants

3.6.5 Competitive Rivalry

3.7 Market Attractiveness Analysis for the Global Meningococcal Vaccines Market, by Geography

Chapter 4 Global Meningococcal Vaccines Market, by Type

4.1 Introduction

4.1.1 Global Meningococcal Vaccines Market Revenue, by Type, 2011 - 2019 (USD Million)

4.2 Comparative Analysis: Global Meningococcal Vaccines Market, by Type, 2012 & 2018 (Value %)

4.3 Polysaccharide Meningococcal Vaccines

4.3.1 Global Polysaccharide Vaccines Market Revenue, by Brand, 2011 - 2019 (USD Million)

4.3.2 Menomune

4.3.2.1 Global Menomune Market Revenue, 2011 - 2019 (USD Million)

4.3.3 Mencevax

4.3.3.1 Global Mencevax Market Revenue, 2011 – 2014 (USD Million)

4.3.4 NmVac4-A/C/Y/W-135

4.3.4.1 Global NmVac4 Market Revenue, 2011 – 2015 (USD Million)

4.3.5 Others (Bi Meningo, Quadri Meningo)

4.3.5.1 Global Other Polysaccharide Vaccines Market Revenue, 2011 – 2019 (USD Million)

4.4 Conjugate Meningococcal Vaccines

4.4.1 Global Conjugate Vaccines Market Revenue, by Brand, 2011 - 2019

4.4.2 Menactra

4.4.2.1 Global Menactra Market Revenue, 2011 - 2019 (USD Million)

4.4.3 Menveo

4.4.3.1 Global Menveo Market Revenue, 2011 - 2019 (USD Million)

4.4.4 NeisVac-C

4.4.4.1 Global NeisVac-C Market Revenue, 2011 - 2019 (USD Million)

4.4.5 Nimenrix

4.4.5.1 Global Nimenrix Market Revenue, 2012 - 2019 (USD Million)

4.4.6 Meningitec

4.4.6.1 Global Meningitec Market Revenue, 2011 - 2019 (USD Million)

4.4.7 Menjugate (Meningococcal Group C- CRM197 Conjugate Vaccine)

4.4.7.1 Global Menjugate Market Revenue, 2011 - 2019 (USD Million)

4.4.8 MenAfriVac

4.4.8.1 Global MenAfriVac Market Revenue, 2011 - 2019 (USD Million)

4.5 Combination Meningococcal Vaccines

4.5.1 Global Combination Vaccines Market Revenue, by Brand, 2011 - 2019 (USD Million)

4.5.2 MenHibrix

4.5.2.1 Global MenHibrix Market Revenue, 2013 - 2019 (USD Million)

4.5.3 Menitorix

4.5.3.1 Global Menitorix Market Revenue, 2011 - 2019 (USD Million)

4.6 Pipeline Analysis

4.6.1 Global Meningococcal Vaccines Market Pipeline Forecast, by Brand, 2011 - 2019 (USD Million)

4.6.2 Bexsero

4.6.2.1 Global Bexsero Market Revenue, 2013 - 2019 (USD Million)

4.6.3 MnB rLP2806

4.6.3.1 Global MnB rLP2806 Market Revenue, 2017 - 2019 (USD Million)

4.6.4 NmVac4-A/C/Y/W-135-DT

4.6.4.1 Global NmVac4 DT Market Revenue, 2015 - 2019 (USD Million)

Chapter 5 Global Meningococcal Vaccines Market, by Geography

5.1 Introduction

5.1.1 Global Meningococcal Vaccines Market Revenue, by Geography, 2011 - 2019 (USD Million)

5.2 North America

5.2.1 North America Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

5.3 Europe

5.3.1 Europe Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

5.4 Asia-Pacific

5.4.1 Asia-Pacific Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

5.5 Rest of the World

5.5.1 Rest of the World Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Competitive Landscape

6.1 Market Share by Key Players, 2012 (Value %)

6.1.1 Methodology

6.1.2 Analysis

Chapter 7 Recommendations

7.1 Focus on Low Cost of Manufacturing

7.2 Developing Animal Component Free and Halal Vaccines

7.3 Tapping Emerging Markets

7.4 Collaborating With Community Pharmacies

Chapter 8 Company Profiles

8.1 Baxter International, Inc.

8.1.1 Company Overview

8.1.2 Financial Overview

8.1.3 Product Portfolio

8.1.4 Business Strategies

8.1.5 Recent Developments

8.2 Biomed Pvt. Ltd.

8.2.1 Company Overview

8.2.2 Financial Overview

8.2.3 Product Portfolio

8.2.4 Business Strategies

8.2.5 Recent Developments

8.3 GlaxoSmithKline plc

8.3.1 Company Overview

8.3.2 Financial Overview

8.3.3 Product Portfolio

8.3.4 Business Strategies

8.3.5 Recent Developments

8.4 JN-International Medical Corporation

8.4.1 Company Overview

8.4.2 Financial Overview

8.4.3 Product Portfolio

8.4.4 Business Strategies

8.4.5 Recent Developments

8.5 Novartis International AG

8.5.1 Company Overview

8.5.2 Financial Overview

8.5.3 Product Portfolio

8.5.4 Business Strategies

8.5.5 Recent Developments

8.6 Nuron Biotech, Inc.

8.6.1 Company Overview

8.6.2 Financial Overview

8.6.3 Product Portfolio

8.6.4 Business Strategies

8.6.5 Recent Developments

8.7 Pfizer, Inc.

8.7.1 Company Overview

8.7.2 Financial Overview

8.7.3 Product Portfolio

8.7.4 Business Strategies

8.7.5 Recent Developments

8.8 Sanofi SA

8.8.1 Company Overview

8.8.2 Financial Overview

8.8.3 Product Portfolio

8.8.4 Business Strategies

8.8.5 Recent Developments

8.9 Serum Institute of India Ltd.

8.9.1 Company Overview

8.9.2 Financial Overview

8.9.3 Product Portfolio

8.9.4 Business Strategies

8.9.5 Recent Developments

List of Figures

FIG.1 Global Meningococcal Vaccines Market Segmentation

FIG.2 Global Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

FIG.3 Comparative Analysis: Global Meningococcal Vaccines Market, by Geography, 2012 & 2019 (Value %)

FIG.4 Risk Factors for Meningococcal Disease

FIG.5 Clinical Manifestations of Meningococcal Disease

FIG.6 Porter's Five Forces Analysis: Global Meningococcal Vaccines Market

FIG.7 Market Attractiveness Analysis: Global Meningococcal Vaccines Market, by Geography

FIG.8 Comparative Analysis: Global Meningococcal Vaccines Market, by Type, 2012 & 2019 (Value %)

FIG.9 Global Menomune Market Revenue, 2011 – 2019 (USD Million)

FIG.10 Global Mencevax Market Revenue, 2011 – 2014 (USD Million)

FIG.11 Global NmVac4 Market Revenue, 2011 – 2015 (USD Million)

FIG.12 Global Other Polysaccharide Vaccines Market Revenue, 2011 – 2019 (USD Million)

FIG.13 Global Menactra Market Revenue, 2011 – 2019 (USD Million)

FIG.14 Global Menveo Market Revenue, 2011 – 2019 (USD Million)

FIG.15 Global NeisVac-C Market Revenue, 2011 – 2019 (USD Million)

FIG.16 Global Nimenrix Market Revenue, 2012 – 2019 (USD Million)

FIG.17 Global Meningitec Market Revenue, 2011 – 2019 (USD Million)

FIG.18 Global Menjugate Market Revenue, 2011 – 2019 (USD Million)

FIG.19 Global MenAfriVac Market Revenue, 2011 – 2019 (USD Million)

FIG.20 Global MenHibrix Market Revenue, 2013 – 2019 (USD Million)

FIG.21 Global Menitorix Market Revenue, 2011 – 2019 (USD Million)

FIG.22 Global Bexsero Market Revenue, 2013 – 2019 (USD Million)

FIG.23 Global MnB rLP2806 Market Revenue, 2017 – 2019 (USD Million)

FIG.24 Global NmVac4 DT Market Revenue, 2015 – 2019 (USD Million)

FIG.25 North America Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

FIG.26 Europe Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

FIG.27 Asia-Pacific Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

FIG.28 Rest of the World Meningococcal Vaccines Market Revenue, 2011 – 2019 (USD Million)

FIG.29 Market Share Analysis: Meningococcal Vaccines Market, 2012 (Value %)

FIG.30 Baxter International, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

FIG.31 GlaxoSmithKline plc: Annual Revenue, 2010 – 2012 (USD Million)

FIG.32 Novartis International AG: Annual Revenue, 2010 – 2012 (USD Million)

FIG.33 Pfizer, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

FIG.34 Sanofi SA: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Meningococcal Vaccines Market

TABLE 3 Global Meningococcal Vaccines Market Revenue, by Type, 2011 - 2019 (USD Million)

TABLE 4 Global Polysaccharide Vaccines Market Revenue, by Brand, 2011 – 2019 (USD Million)

TABLE 5 Global Conjugate Vaccines Market Revenue, by Brand, 2011 – 2019 (USD Million)

TABLE 6 Global Combination Vaccines Market Revenue, by Brand, 2011 - 2019 (USD Million)

TABLE 7 Global Meningococcal Vaccines Market Pipeline Forecast, by Brand, 2011 - 2019 (USD Million)

TABLE 8 Global Meningococcal Vaccines Market Revenue, by Geography, 2011 - 2019 (USD Million)

To order this report: Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019http://www.reportlinker.com/p02116909/Meningococcal-Vaccines-Market-Polysaccharide-Conjugate-and-Combination-Vaccines-along-with-Pipeline-Analysis---Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast-2013---2019.html

__________________________Contact Clare: [email protected]: (339)-368-6001Intl: +1 339-368-6001

SOURCE Reportlinker